Roca, H., Varsos, Z. S., & Pienta, K. J. (2009). CCL2 Is a Negative Regulator of AMP-Activated Protein Kinase to Sustain mTOR Complex-1 Activation, Survivin Expression, and Cell Survival in Human Prostate Cancer PC3 Cells. Neoplasia Press Inc.
Citação norma ChicagoRoca, Hernan, Zachary S. Varsos, and Kenneth J. Pienta. CCL2 Is a Negative Regulator of AMP-Activated Protein Kinase to Sustain MTOR Complex-1 Activation, Survivin Expression, and Cell Survival in Human Prostate Cancer PC3 Cells. Neoplasia Press Inc, 2009.
Citação norma MLARoca, Hernan, Zachary S. Varsos, and Kenneth J. Pienta. CCL2 Is a Negative Regulator of AMP-Activated Protein Kinase to Sustain MTOR Complex-1 Activation, Survivin Expression, and Cell Survival in Human Prostate Cancer PC3 Cells. Neoplasia Press Inc, 2009.